Abstract:Graft arteriosclerois (GA), also called allograft vasculopathy, is a pathologic lesion that develops over months to years in transplanted organs characterized by diffuse, circumferential stenosis of the entire graft vascular tree. The most critical component of GA pathogenesis is the proliferation of smooth muscle-like cells within the intima. When a human coronary artery segment is interposed into the infra-renal aortae of immunodeficient mice, the intimas could be expand in response to adoptively transferred human T cells allogeneic to the artery donor or exogenous human IFN-γ in the absence of human T cells. Interposition of a mouse aorta from one strain into another mouse strain recipient is limited as a model for chronic rejection in humans because the acute cell-mediated rejection response in this mouse model completely eliminates all donor-derived vascular cells from the graft within two-three weeks. We have recently developed two new mouse models to circumvent these problems. The first model involves interposition of a vessel segment from a male mouse into a female recipient of the same inbred strain (C57BL/6J). Graft rejection in this case is directed only against minor histocompatibility antigens encoded by the Y chromosome (present in the male but not the female) and the rejection response that ensues is sufficiently indolent to preserve donor-derived smooth muscle cells for several weeks. The second model involves interposing an artery segment from a wild type C57BL/6J mouse donor into a host mouse of the same strain and gender that lacks the receptor for IFN-γ followed by administration of mouse IFN-γ (delivered via infection of the mouse liver with an adenoviral vector. There is no rejection in this case as both donor and recipient mice are of the same strain and gender but donor smooth muscle cells proliferate in response to the cytokine while host-derived cells, lacking receptor for this cytokine, are unresponsive. By backcrossing additional genetic changes into the vessel donor, both models can be used to assess the effect of specific genes on GA progression. Here, we describe detailed protocols for our mouse GA models.

Mouse Models of Renal Allograft Transplant Rejection: Methods to Investigate Chemokine-GAG Interaction and Therapeutic Blockade.

Mouse Model Established by Early Renal Transplantation after Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection.

Mouse Models for Graft Arteriosclerosis.

Strategies for Successfully Establishing A Kidney Transplant in A Mouse Model

Biomarkers for Renal Transplantation: Where Are We?

Kidney Subcapsular Allograft Transplants As a Model to Test Virus-Derived Chemokine-Modulating Proteins As Therapeutics

Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine–Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune Damage

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

Cxcl10 and Cxcl13 Expression Were Highly Up-Regulated in Peripheral Blood Mononuclear Cells in Acute Rejection and Poor Response to Anti-Rejection Therapy

Modulating Heparan Sulfation and Disaccharide Content Significantly Blocks Early Rejection in Mouse Renal Transplants

Understanding the acute rejection of renal allograft (video)

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

Pre-treatment of Allografts to Modifying Chemokine: Glycosaminoglycan Pathways Reduces Transplant Rejection

Developing Renal Allograft Surveillance Strategies – Urinary Biomarkers of Cellular Rejection

Chemokine Receptors and Transplantation.

CXCL9 and CXCL10 Accelerate Acute Transplant Rejection Mediated by Alloreactive Memory T Cells in a Mouse Retransplantation Model

Rat Renal Transplant Model for Mixed Acute Humoral and Cellular Rejection: Weak Correlation of Serum Cytokines/chemokines with Intragraft Changes.

Acute cellular rejection of human renal tissue by adoptive transfer of allogeneic human peripheral blood mononuclear cells into chimeric rats: sequential gene expression of cytokines, chemokines and cytolytic effector molecules, and their regulation by CTLA-4-Ig

Characterization and Proteomic Analyses of Proinflammatory Cytokines in a Mouse Model of Liver Transplant Rejection

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Chronic Rejection After Kidney Transplantation